ArticleBlood advances2018

CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia.

Ying-Ping Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.